The use of prostate-specific membrane antigen (PSMA)-directed applications in modern
prostate cancer management has evolved rapidly over the past few years, helping to …

Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein expressed in
the majority of prostate cancer (PCa). PSMA has an enzymatic function that makes metabolic …

Background In the initial staging of patients with high-risk prostate cancer (PCa), prostate-
specific membrane antigen positron emission tomography (PSMA-PET) has been …

Objectives To investigate whether patients with suspected pelvic lymph node metastases
(molecular imaging [mi] N1) on staging prostate‐specific membrane antigen (PSMA) …

Our objective was to determine the diagnostic value of prostate-specific membrane antigen
(PSMA) PET/CT in staging men with newly diagnosed unfavorable intermediate-risk prostate …

Prostate specific membrane antigen positron emission tomography (PSMA PET) is an
excellent molecular imaging technique for prostate cancer. Currently, PSMA PET for patients …

Objectives To investigate the association between intraprostatic, intratumoral maximum
standardised uptake values (SUVmax) on prostate‐specific membrane antigen (PSMA) …

Background To clarify the clinical roles of changes in testosterone (T) levels with a cut‐off
level of 20 ng/dL as predictive factors for prostate cancer patients treated with degarelix …

Zusammenfassung Das Prostatakarzinom (PCa) ist die häufigste Tumorerkrankung des
Mannes. Während Patienten mit niedrigem Risikoprofil aktiv überwacht werden können …

Choosing the best treatment for a patient with cancer involves gathering as much
information as possible about the disease. Recent advances in prostate cancer imaging now …